A-337

N/A

Report date: 2026/03/19 17:23:55

Base Information

Drug NameA-337

Drug Alias NameA-337

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionT cell surface glycoprotein CD3 stimulantsEpithelial cell adhesion molecule modulators

TargetsT cell surface glycoprotein CD3Epithelial cell adhesion molecule

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesEvive Biotech Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesITabMed Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A